Top Stories Affecting Dow 30 Healthcare Stocks This Week

Johnson & Johnson (NYSE:JNJ): Current price $76.70

Johnson & Johnson said that based on its preliminary evaluation of the impact of the Venezuelan government’s decision to devalue its currency effective February 13th, it will incur a charge of around $100 million to net income in the first quarter of 2013, or roughly a four cent negative impact to earnings per share. This charge is connected with the remeasurement of the local balance sheet at the date of the devaluation, and it is not anticipated that there will be an impact to earnings per share guidance for full-year 2013 that was previously reported on January 22nd.